Brain metastases in EGFR-positive non-small cell lung cancer: the way to the sanctuary becomes less winding

被引：5
|
作者：
Passaro, Antonio [1 ]
Gianoncelli, Letizia [1 ]
Stati, Valeria [1 ]
de Marinis, Filippo [1 ]
机构：
[1] European Inst Oncol IRCCS, IEO, Div Thorac Oncol, Via G Ripamonti 435, I-20141 Milan, Italy
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2019年 / 7卷
关键词：
MUTANT NSCLC; OSIMERTINIB;
D O I：
10.21037/atm.2019.04.04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] A Single-Institution Review of Patients with EGFR-positive Non-Small Cell Lung Cancer with Brain Metastases at Presentation
    Prezzano, K. M.
    Hermann, G. M.
    Farrugia, M. K.
    Prasad, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E87 - E87
  • [2] AFATINIB FOR THE TREATMENT OF PATIENTS WITH EGFR-POSITIVE NON-SMALL CELL LUNG CANCER
    Bowles, D. W.
    Weickhardt, A.
    Jimeno, A.
    DRUGS OF TODAY, 2013, 49 (09) : 523 - 535
  • [3] Looking for the high way in EGFR-positive non-small cell lung cancer through the evaluation of survival endpoints
    Passaro, Antonio
    de Marinis, Filippo
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S334 - S338
  • [4] Upfront Treatment With Osimertinib vs. Osimertinib and Radiotherapy for Patients With EGFR-Positive Non-Small Cell Lung Cancer Brain Metastases
    Dohm, A. E.
    Tang, J.
    Mills, M. N.
    Perez, B. A.
    Robinson, T. J.
    Creelan, B.
    Yu, H. H. M.
    Oliver, D. E.
    Ahmed, K. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (02): : E14 - E14
  • [5] Dacomitinib in EGFR-positive non-small cell lung cancer: an attractive but broken option
    Passaro, Antonio
    de Marinis, Filippo
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S100 - S102
  • [6] Patient Age and EGFR-positive Non-small Cell Lung Cancer: A Multicenter Retrospective Study
    Maezawa, Yosuke
    Taguchi, Manato
    Kawakami, Takeshi
    Inui, Toshihide
    Okauchi, Shinichiro
    Numata, Takeshi
    Shiozawa, Toshihiro
    Miyazaki, Kunihiko
    Nakamura, Ryota
    Iguchi, Kesato
    Endo, Takeo
    Sakamoto, Tohru
    Satoh, Hiroaki
    Hizawa, Nobuyuki
    ANTICANCER RESEARCH, 2024, 44 (04) : 1751 - 1757
  • [7] Pulsatile Erlotinib in EGFR-Positive Non-Small-Cell Lung Cancer Patients With Leptomeningeal and Brain Metastases: Review of the Literature
    How, Joan
    Mann, Janelle
    Laczniak, Andrew N.
    Baggstrom, Maria Q.
    CLINICAL LUNG CANCER, 2017, 18 (04) : 354 - 363
  • [8] EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer
    Sonoda, Tomoaki
    Nishikawa, Shingo
    Sakakibara, Rie
    Saiki, Masafumi
    Ariyasu, Ryo
    Koyama, Junji
    Kitazono, Satoru
    Yanagitani, Noriko
    Horiike, Atsushi
    Ohyanagi, Fumiyoshi
    Ninomiya, Hironori
    Ishikawa, Yuichi
    Nishio, Makoto
    RESPIRATORY MEDICINE CASE REPORTS, 2018, 24 : 19 - 21
  • [9] The efficacy of osimertinib in patients with EGFR-positive non-small cell lung cancer with malignant pleural effusion
    Kiritani, Ayu
    Amino, Yoshiaki
    Uchibori, Ken
    Akita, Takahiro
    Harutani, Yuhei
    Ogusu, Shinsuke
    Tsugitomi, Ryosuke
    Manabe, Ryo
    Ariyasu, Ryo
    Kitazono, Satoru
    Yanagitani, Noriko
    Nishio, Makoto
    ANNALS OF ONCOLOGY, 2022, 33 : S510 - S511
  • [10] Real-world assessment of afatinib for patients with EGFR-positive non-small cell lung cancer
    Satoshi Igawa
    Taihei Ono
    Masashi Kasajima
    Seiichiro Kusuhara
    Sakiko Otani
    Tomoya Fukui
    Masanori Yokoba
    Masaru Kubota
    Masato Katagiri
    Hisashi Mitsufuji
    Jiichiro Sasaki
    Katsuhiko Naoki
    Investigational New Drugs, 2020, 38 : 1906 - 1914
12345